- Home
- TPST vs CCM Comparison
TPST vs CCM Comparison
Compare TPST & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- CCM
- Stock Information
- Founded
- TPST 2011
- CCM 1997
- Country
- TPST United States
- CCM China
- Employees
- TPST N/A
- CCM N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- TPST Health Care
- CCM Health Care
- Exchange
- TPST Nasdaq
- CCM Nasdaq
- Market Cap
- TPST 33.0M
- CCM 33.3M
- IPO Year
- TPST N/A
- CCM 2009
- Fundamental
- Price
- TPST $7.52
- CCM $5.68
- Analyst Decision
- TPST Hold
- CCM
- Analyst Count
- TPST 3
- CCM 0
- Target Price
- TPST $30.00
- CCM N/A
- AVG Volume (30 Days)
- TPST 125.6K
- CCM 2.3K
- Earning Date
- TPST 08-07-2025
- CCM 04-25-2025
- Dividend Yield
- TPST N/A
- CCM N/A
- EPS Growth
- TPST N/A
- CCM N/A
- EPS
- TPST N/A
- CCM N/A
- Revenue
- TPST N/A
- CCM $52,603,198.00
- Revenue This Year
- TPST N/A
- CCM N/A
- Revenue Next Year
- TPST N/A
- CCM N/A
- P/E Ratio
- TPST N/A
- CCM N/A
- Revenue Growth
- TPST N/A
- CCM N/A
- 52 Week Low
- TPST $5.35
- CCM $3.80
- 52 Week High
- TPST $30.03
- CCM $10.90
- Technical
- Relative Strength Index (RSI)
- TPST 57.33
- CCM 38.23
- Support Level
- TPST $7.06
- CCM $5.50
- Resistance Level
- TPST $7.18
- CCM $5.95
- Average True Range (ATR)
- TPST 0.27
- CCM 0.19
- MACD
- TPST 0.05
- CCM 0.01
- Stochastic Oscillator
- TPST 88.57
- CCM 39.74
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.